Forward PE Ratio: 13.58
The forward PE ratio is 13.58 as of Thursday, July 9, 2026.
Forward PE Ratio (13.58) = Close Price ($409.01) / Consensus Forward EPS ($30.23)
HCA Forward PE Ratio Metrics
FORWARD PE RATIO
13.58
HCA Competitors' Forward PE Ratio
HCA Healthcare, Inc.
Market Cap
$90.73B
Forward PE Ratio
13.58
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| HCA Healthcare, Inc. (HCA) | $90.73B | 13.58 |
| Elevance Health Inc. (ELV)vs › | $91.29B | 15.46 |
| McKesson Corporation (MCK)vs › | $92.82B | 20.99 |
| Cigna Corporation (CI)vs › | $77.19B | 9.51 |
| GSK plc (GSK)vs › | $105.09B | 14.68 |
| Medtronic plc (MDT)vs › | $105.46B | 14.86 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $68.81B | 14.31 |
| Boston Scientific Corporation (BSX)vs › | $66.87B | 13.33 |
| Bristol-Myers Squibb Company (BMY)vs › | $118.32B | 9.11 |
| Cencora, Inc. (COR)vs › | $58.85B | 17.41 |
Trailing vs Forward
Trailing P/E
14.1
reported TTM EPS
Forward P/E
13.6
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $30.23 implies +4.0% EPS growth vs the reported trailing $29.08.
Forward P/E by Fiscal Year
View All Analyst EstimatesAt today's $409.01 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $30.23 | $29.25 – $30.76 | 16 | 13.5x |
| 2027-12-31 | $33.18 | $32.31 – $34.76 | 16 | 12.3x |
| 2028-12-31 | $37.22 | $35.26 – $39.02 | 9 | 11.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
Forward PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Forward PE Ratio FAQ
- What is the forward PE ratio for HCA Healthcare, Inc. (HCA)?
- The forward PE ratio for HCA stock is 13.58.
Related Metrics
About HCA Healthcare, Inc.
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Samuel N. Hazen